Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Chip is a wealth investing & savings app that aims to foster financial prosperity for today's generation
days to go:
Expired
investment:
£5,083,686
Investly are an invoice financing marketplace that help European businesses finance their invoices by bringing them the best price from multiple providers. In 2 years they have financed just over £18m worth of invoices.
days to go:
Expired
investment:
£679,085
Payment fraud and identity verification are real threats to businesses and customers, but Fingopay has developed a solution. A highly secure biometric reader that scans a person's unique finger vein to complete transactions in seconds. Customer details are stored in the cloud and can be used to offer promotions and deals. Successful pilots have been achieved in Brunel University, Copenhagen Business School and Proud Bar in Camden. Fingopay has partnerships with VISA, Worldpay and Nets.
days to go:
Expired
investment:
£1,216,240
Currikulo is an online platform designed to improve the recruitment process. Currikulo allows the employer to easily create a microsite which explains what the company does and also lists job description and the skills needed. All the employee has to do is fill out their skills and previous projects they have worked on and Currikulo will show a list of jobs they are qualified to do globally.
days to go:
Expired
investment:
£20,030
Clim8 is a financial technology company that aims to move billions of pounds of investment into sectors such as clean energy, clean technology, sustainable food, smart mobility, and recycling. It is authorised by the Financial Conduct Authority (FCA). The company quotes United Nations data arguing that the World needs to invest $2.4 trillion every year into clean energy, from now until 2035, to meet climate change targets. Clim8 aims to capitalise on this objective. It launched its app on iOS and Android in private beta in October 2020 and then in the App Store in March 2021. It claims that its users have invested from £25 up to £97,000. The company has raised £5 million in venture capital to date, secured up to £2 million in airtime for equity from Channel 4 Ventures, and garnered a 4.8 star rating in the App Store, from a cumulative 100 reviews. The company will use the investment to accelerate user acquisition and launch new product offerings including pensions.
days to go:
Expired
investment:
£2,849,790
GRNDHOUSE is a fitness company specialising in the strength training vertical. The company hosts live strength training classes with metrics delivered to its community-centric app. The app allows users access to a weekly structure of low- and high-impact classes that focus on each body part to ultimately condition the entire body throughout the week. Users can even post their results on their user feed to champion and inspire each other, win badges and awards for their progress and gather their health data over time to see their improvements. GRNDHOUSE argues that it has acquired 1500 paying members to date via organic marketing on its portal. The company has also earned revenue worth £266,000 since its launch and featured in the Telegraph, Cosmopolitan, Business Insider and others. It states it will use 30% of the investment to develop its film studio and equipment, 45% towards paying salaries of its technology, marketing, sales, and instructor teams, 20% towards marketing, and 5% towards hardware stock.
days to go:
Expired
investment:
£1,453,651
